International
Medical Cannabis Bike Tour: How a group of cyclists funded a clinical trial for cannabis in glioblastoma
In 2013 the Medical Cannabis Bike Tour began raising funds to support the work of a team of researchers from Complutense University, in Madrid, led by Manuel Guzmán and Guillermo Velasco, which investigated the effects of cannabinoids on cancer cells and their potential as a treatment for glioblastoma. 10 years later, more than 400.000 euros were raised during bicycle tours that covered Spain, the Netherlands, Germany, Belgium, Slovenia, Italy, the Czech Republic and Austria. Now, the first independent clinical trial on the potential of cannabis in glioblastoma will finally move forward, in Spain, with a preparation made available by Tilray Medical.
Founded by Luc Krol from the Cannabis Seed Gene Bank Paradise seeds, from the Netherlands, and Matej Munih, from Snail Rolling Papers, the Medical Bike Tour Foundation mobilized the European cannabis community, attracting significant industry sponsorship across five events. Proceeds from the kilometers cycled by the group of cyclists are now financing this clinical trial.
The Medical Cannabis Bike Tour toured several countries over almost 10 years to raise funds for a clinical trial
Over the next 18 months, the trial will study the synergistic antitumor effect observed in the preclinical phase of the combination of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in traditional cancer treatments, using concomitant temozolomide and radiotherapy. The supplier of medical cannabis is Tilray Medical, which provided a medicine with EU-GMP pharmaceutical quality in a 1:1 THC/CBD ratio for the trial.
Conducted in eight medical centers in Spain specialized in neuro-oncology, the study recruited 30 patients and is led by researcher Juan Manuel Sepúlveda Sánchez, from GEINO (Spanish Neuro-Oncology Research Group) and has the collaboration of scientists from the Complutense University of Madrid and MFAR, a company focused on academic clinical research.
Cannabis: a new therapeutic route for brain tumors
Researcher Guillermo Velasco, from the Complutense University of Madrid, receives the prize for one of the various stages of the Medical Cannabis Bike Tour by Luc Krol, from Paradise Seeds
Juan Sepúlveda told Cannareporter that “biological evidence has been accumulating for more than 15 years that cannabinoids have anti-tumor activity in the most aggressive brain tumors, glioblastomas. However, no clinical trials have been carried out to prove this hypothesis in patients, perhaps due to the lack of commercial interest in these medicines. With this clinical trial, we can finally study the effect of cannabinoids on tumors that have little active treatment and help give our patients a new option, but also open a therapeutic avenue.” Guillermo Velasco, researcher at Complutense University, also said that this trial represents a crucial milestone in the study of the anti-tumor action of cannabinoids. “It is a long-term project, which we have been developing for over 20 years. Stemming from initial, almost fortuitous observations that Δ9-tetrahydrocannabinol (THC) has the ability to promote the death of glioma cells, our work has led us to understand the mechanism by which cannabinoids exert their anti-cancer actions on cells. brain tumors. Likewise, our preclinical studies in animal models demonstrated a promising synergistic anti-tumor effect by combining Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) with temozolomide, thus contributing to establishing the scientific basis for the development of this study. clinical".
Velasco further added that, “as a basic scientist, being able to translate our findings into something potentially useful for patients is the ultimate aspiration, and so we are excited to see the study begin and extremely grateful to everyone who made it possible.” , including our partners Medical Cannabis Bike tour, GEINO, Tilray and MFAR, as well as former and current researchers in our group and all our national and international collaborators”.
The researcher also said that he hopes that “the results of the trial will contribute to providing new hope and therapeutic option for patients with glioblastoma”.
Luc Krol, from the Medical Cannabis Bike Tour (MCBT) added that “the world was very different when we started the Tour 10 years ago. In the pre-legalization era, the term 'medical cannabis' was still seen by many people as a fantasy. However, we believed it was possible. The fact that MCBT can independently fund a clinical trial in the name of science, not profit, is incredible, thanks to the sponsors and participants who made this happen. We hope this trial reflects the hope illuminated by scientific research for the participants involved.”
Denise Faltischek, director of strategy and international business at Tilray, stated that “this innovative test is more than an opportunity for Tilray: it is a beacon of hope for patients suffering from glioblastoma. Our role in this initiative expands our commitment to medical research, taking us one step closer to unlocking the full therapeutic potential of medical cannabis.”
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 21st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “Say What? Lisbon” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura directed the documentary “Pacientes” and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.
Thailand has found a solution where European countries still see a problem.
Reading Time: 13 minutes On my second trip to Thailand, I was once again pleasantly surprised. After visiting several...
The Royal Thai Embassy in Tokyo promotes "Adapting International Hemp to Japan's New Regulations"
Reading Time: 3 minutes The International Business Meeting “Adapting the International Market...” will take place tomorrow, November 13, 2025.
Portugal: Infarmed updates lists and removes licenses from two more medicinal cannabis companies.
Reading Time: 2 minutes. Infarmed has updated the public list of entities licensed for activities with medicinal cannabis in Portugal. The...
Portocanna strengthens its Hexacan portfolio with a new sublingual solution containing 20% THC.
Reading Time: 2 minutes. The Portuguese company Portocanna announced the launch of Hexacan® Hexa 01 Cannabis Oil Extract THC 20%,...
Cypress Hill confirmed for Rock in Rio Lisboa 2026
Reading Time: 2 minutes. The legendary American band Cypress Hill, whose hits "Insane in the Brain" and "Hits from the Bong"...
USA: Green Thumb Industries workers secure collective agreement after 45-day strike.
Reading Time: < 1 minute Workers at Green Thumb Industries, one of the largest multi-state cannabis companies in the United States...
Switzerland: Pacrim takes control of Medropharm and prepares for a new phase of expansion in medicinal cannabis.
Reading Time: 2 minutes. Pacrim has acquired two-thirds of the Swiss company Medropharm, thus gaining control of the company and its operations.
South Africa: Researchers discover rare phenolic compounds in cannabis leaves.
Reading Time: 4 minutes. Researchers at Stellenbosch University in South Africa have discovered that flavoalkaloids are produced in the leaves of the plant...
Covilhã – Dismantling of two cannabis greenhouses
Reading Time: < 1 minute The Castelo Branco Territorial Command, through the Criminal Investigation Unit (NIC) of Covilhã, in...
Tokyo will host the Japan International Hemp Expo on November 14th and 15th, 2025.
Reading Time: 4 minutes. For the first time since the legal reform, Japan opens its doors to the global hemp industry...
